GLYCOLIPID AND INFLAMMATORY STATUS ANALYSIS IN METFORMIN-TREATED TYPE 2 DIABETICS
Department of Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences -National Institute of the Republic of Serbia, University of Belgrade , Belgrade , Serbia
Department of Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences National Institute of the Republic of Serbia , University of Belgrade , Belgrade , Serbia
Department of Radiobiology and Molecular Genetics , VINČA Institute of Nuclear Sciences National Institute of the Republic of Serbia , University of Belgrade , Belgrade , Serbia
Department of Radiobiology and Molecular Genetics, VINČA Institute of Nuclear Sciences National Institute of the Republic of Serbia , University of Belgrade , Belgrade , Serbia
Department of Radiobiology and Molecular Genetics , VINČA Institute of Nuclear Sciences National Institute of the Republic of Serbia , University of Belgrade , Belgrade , Serbia
Department of Endocrinology and Diabetes, Clinic for Internal Medicine, Clinical Hospital Center Zemun , Belgrade , Serbia
Faculty of Medicine, University of Belgrade , Belgrade , Serbia
Primary Health Care Center, Faculty of Medicine, University of Montenegro , Podgorica , Montenegro
Department of Radiobiology and Molecular Genetics , VINČA Institute of Nuclear Sciences National Institute of the Republic of Serbia , University of Belgrade , Belgrade , Serbia
Volume 40, Issue 1 (2026)
Abstract
Introduction: Type 2 diabetes mellitus (T2DM) is linked to increased vascular morbidity and mortality. Well-controlled diabetes is indicated by effective glycemic and HbA1c regulation and low-grade inflammation management. This study evaluates glycolipid control and inflammatory status in T2DM patients on metformin.
Methods: A pilot study involved 11 participants divided into two groups: a T2DM group on metformin therapy and a control, non-diabetic group. Demographic, clinical, anthropometric, glycolipid (glycemia, HbA1c, TC, LDL-C, HDL-C, TG), and inflammatory parameters (CRP, FFA, PL, UA, FLI) were evaluated.
Results: Significant intergroup differences were found in glycemia, HbA1c, TC, LDL-C, UA, FLI, and WC. Glycemia influenced PL (p<0.05), UA (p<0.01), and FLI (p<0.01), while HbA1c affected UA (p<0.05) and FLI (p<0.01). LDL-C and HDL-C impacted UA (p<0.05, p<0.01). Age affected FLI (p<0.05), gender influenced PL (p<0.01), and BW, BH, WC, and BMI significantly impacted UA and FLI (p<0.01).
Conclusion: T2DM patients showed signs of low-grade systemic inflammation, emphasizing the need for comprehensive diabetes management and early cardiovascular risk detection. Intensified interventions are necessary for patients with inadequate glycemic control on metformin.
Keywords
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Article metrics
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
